Active, not recruitingPhase 2NCT06327152
Caffeine Use in the Management of Preterm Infants
Studying Apnea of prematurity
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, Irvine
- Principal Investigator
- Cherry Uy, MDUC Irvine
- Intervention
- Caffeine(drug)
- Enrollment
- 80 enrolled
- Eligibility
- All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- UC Irvine Medical Center, Orange, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06327152 on ClinicalTrials.govOther trials for Apnea of prematurity
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07324941The Role of Electroencephalography in Caffeine Discontinuation Timing in Premature InfantsUludag University
- RECRUITINGNANCT06374147"Prapela® SVS Incubator Pad for Apnea of PrematurityTufts Medical Center
- RECRUITINGNANCT07396103Efficacy of PIMUN by Reducing Intermittent Hypoxia EventsPontificia Universidad Catolica de Chile
- ACTIVE NOT RECRUITINGPHASE1NCT06905496Apnea of Prematurity Results in Respiratory Distress and Cyanosis. Caffeine Citrate Can Treat It.Nishtar Medical University
- RECRUITINGPHASE4NCT06401083The Effect of an Additional Pre-extubational Loading Dose of Caffeine-citrateSemmelweis University
- ACTIVE NOT RECRUITINGNCT05196646Detection of CardioRespiratory Events Using Acoustic Monitoring in Preterm Infants on CPAPMcGill University Health Centre/Research Institute of the McGill University Health Centre
- RECRUITINGNANCT05298748The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm InfantsCase Western Reserve University
- RECRUITINGPHASE3NCT04430790Doxapram Therapy in Preterm Infants (DOXA Trial)Erasmus Medical Center